Crestline Management, L.P. Portfolio Stock Holdings

According to the SEC 13F filed on August 14, 2026, Crestline Management, L.P. disclosed 3 stock positions valued at approximately $53.48M as of quarter-end June 30, 2026. The largest holdings include DENALI THERAPEUTICS INC, SANA BIOTECHNOLOGY INC, and 8X8 INC NEW.

Report Period: June 30, 2026
No. of Stocks: 3
Portfolio Value: $53.48M

Holdings by Sector

Crestline Management, L.P. Portfolio Holdings in Q2 2026

3 holdings in the latest reporting period.

Page 1 of 1

Company	Symbol	Sector	Portfolio %	Shares	Change (Shares)	Change %	Value
DENALI THERAPEUTICS INC	DNLI	Healthcare	91.90%	1,910,732	-300,000	-13.57%	$49,144,027
SANA BIOTECHNOLOGY INC	SANA	Healthcare	4.93%	755,736	-	-	$2,637,619
8X8 INC NEW	EGHT	Technology	3.17%	990,850	-	-	$1,694,354